Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6343
Gene Symbol: SCT
SCT
0.020 Biomarker disease BEFREE Pancreatic fluid secretion stimulated with a physiological dose of secretin (0.03 nmol/kg per hour) in PCK rats was significantly smaller than that in WT, but the differences were not significant at higher doses. 22647734 2012
Entrez Id: 4601
Gene Symbol: MXI1
MXI1
0.020 PosttranslationalModification disease BEFREE These results indicate that expression of proteins related with inflammation and renal fibrosis changes by Mxi1 inactivation in polycystic kidney. 19637234 2009
Entrez Id: 6343
Gene Symbol: SCT
SCT
0.020 Biomarker disease BEFREE Exposure of the cholangiocyte basolateral membrane to CFTR inhibitors [5-nitro-2-(3-phenylpropylamino)-benzoic acid and CFTRinh172], or Cl(-)/HCO(3)(-) exchange inhibitors (4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid disodium salt hydrate and 4-acetamido-4'-isothiocyanato-2,2'-stilbenedisulfonic acid disodium salt hydrate) blocked secretin-stimulated fluid accumulation in PCK but not in normal cysts. 18988797 2008
Entrez Id: 4601
Gene Symbol: MXI1
MXI1
0.020 AlteredExpression disease BEFREE Inactivation of Mxi1 induces Il-8 secretion activation in polycystic kidney. 17350592 2007
Entrez Id: 2056
Gene Symbol: EPO
EPO
0.020 GeneticVariation disease BEFREE Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene. 10200985 1999
Entrez Id: 5311
Gene Symbol: PKD2
PKD2
0.020 AlteredExpression disease BEFREE Immunohistochemical studies have shown that polycystin 1 and polycystin 2 are developmentally regulated and are overexpressed in polycystic kidneys. 9529618 1998
Entrez Id: 2056
Gene Symbol: EPO
EPO
0.020 Biomarker disease BEFREE Erythropoietin in polycystic kidneys. 2794053 1989
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.010 AlteredExpression disease BEFREE <b>Results:</b> Cyclooxygenase-2 expression was up-regulated compared to control kidneys as shown by RNase protection in human polycystic kidneys and immunoblot in mouse Pkd2<sup>WS25/-</sup> kidneys. 30662341 2019
Entrez Id: 284086
Gene Symbol: NEK8
NEK8
0.010 GeneticVariation disease BEFREE The Lewis Polycystic Kidney (LPK) rat phenotype has been characterized and classified as a model of nephronophthisis (NPHP9, caused by mutation of the Nek8 gene) for which polycystic kidneys are one of the main pathologic features. 31005771 2019
Entrez Id: 2736
Gene Symbol: GLI2
GLI2
0.010 AlteredExpression disease BEFREE The treatment of PCK cholangiocytes with cyclopamine inhibited cell proliferative activity that was associated with the inhibition of nuclear translocation of Gli1 and Gli2, and reduced cyclin D1 expression. 30036521 2018
Entrez Id: 2737
Gene Symbol: GLI3
GLI3
0.010 Biomarker disease BEFREE The nuclear expression of Gli1, Gli2, and Gli3 was observed in PCK cholangiocytes by immunocytochemistry. 30036521 2018
Entrez Id: 11261
Gene Symbol: CHP1
CHP1
0.010 GeneticVariation disease BEFREE Comparisons of gene expression profiles in kidney tissues at P22 and P30 in PKD and WT mice revealed that arginine metabolism was significantly activated; 204 differentially expressed genes (DEGs), including <i>Arg1</i>, an arginine metabolism-associated gene, were identified in late-stage polycystic kidneys. 30042193 2018
Entrez Id: 10013
Gene Symbol: HDAC6
HDAC6
0.010 Biomarker disease BEFREE Panobinostat and all three HDAC6 inhibitors decreased hepatorenal cystogenesis in PCK rats. 29366679 2018
Entrez Id: 2735
Gene Symbol: GLI1
GLI1
0.010 AlteredExpression disease BEFREE The treatment of PCK cholangiocytes with cyclopamine inhibited cell proliferative activity that was associated with the inhibition of nuclear translocation of Gli1 and Gli2, and reduced cyclin D1 expression. 30036521 2018
Entrez Id: 383
Gene Symbol: ARG1
ARG1
0.010 AlteredExpression disease BEFREE Multiple-stage macrophage depletion verified that macrophages expressing high ARG1 levels accounted for late-stage cyst enlargement, and inhibiting ARG1 activity significantly retarded cyst growth and effectively lowered the proliferative indices in polycystic kidneys. 30042193 2018
Entrez Id: 11331
Gene Symbol: PHB2
PHB2
0.010 GeneticVariation disease BEFREE Comparisons of gene expression profiles in kidney tissues at P22 and P30 in PKD and WT mice revealed that arginine metabolism was significantly activated; 204 differentially expressed genes (DEGs), including <i>Arg1</i>, an arginine metabolism-associated gene, were identified in late-stage polycystic kidneys. 30042193 2018
Entrez Id: 1778
Gene Symbol: DYNC1H1
DYNC1H1
0.010 GeneticVariation disease BEFREE Comparisons of gene expression profiles in kidney tissues at P22 and P30 in PKD and WT mice revealed that arginine metabolism was significantly activated; 204 differentially expressed genes (DEGs), including <i>Arg1</i>, an arginine metabolism-associated gene, were identified in late-stage polycystic kidneys. 30042193 2018
Entrez Id: 201161
Gene Symbol: CENPV
CENPV
0.010 AlteredExpression disease BEFREE Comparisons of gene expression profiles in kidney tissues at P22 and P30 in PKD and WT mice revealed that arginine metabolism was significantly activated; 204 differentially expressed genes (DEGs), including <i>Arg1</i>, an arginine metabolism-associated gene, were identified in late-stage polycystic kidneys. 30042193 2018
Entrez Id: 9742
Gene Symbol: IFT140
IFT140
0.010 GeneticVariation disease BEFREE Mutations of Ift140 are usually associated with syndromic ciliopathy and may cause isolated diseases such as retinal dystrophy, short ribs, and polycystic kidney. 29195058 2018
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.010 Biomarker disease BEFREE PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice. 28903946 2018
Entrez Id: 51726
Gene Symbol: DNAJB11
DNAJB11
0.010 GeneticVariation disease BEFREE WES identified a DNAJB11 missense variant (p.Pro54Arg) in two family members presenting with non-enlarged polycystic kidneys and a frameshifting change (c.166_167insTT) in a second family with small renal and liver cysts. 29706351 2018
Entrez Id: 10376
Gene Symbol: TUBA1B
TUBA1B
0.010 AlteredExpression disease BEFREE We also assessed effects of ACY-1215 and pasireotide alone and in combination on cell proliferation, cAMP production, and expression of acetylated α-tubulin in vitro in cultured cholangiocytes and the length of primary cilia and the frequency of ciliated cholangiocytes in vivo in PCK rats. 29366679 2018
Entrez Id: 11258
Gene Symbol: DCTN3
DCTN3
0.010 GeneticVariation disease BEFREE Comparisons of gene expression profiles in kidney tissues at P22 and P30 in PKD and WT mice revealed that arginine metabolism was significantly activated; 204 differentially expressed genes (DEGs), including <i>Arg1</i>, an arginine metabolism-associated gene, were identified in late-stage polycystic kidneys. 30042193 2018
Entrez Id: 7187
Gene Symbol: TRAF3
TRAF3
0.010 Biomarker disease BEFREE We observe the TRAF3 genic overexpression of the epithelial cells, which form a tubular branch structure, in polycystic kidneys and to explore the protective effect of TRAF3 on the cystogenesis and progression of PKD. 28185403 2017
Entrez Id: 51364
Gene Symbol: ZMYND10
ZMYND10
0.010 Biomarker disease BEFREE Loss of zinc finger MYND-type containing 10 (zmynd10) affects cilia integrity and axonemal localization of dynein arms, resulting in ciliary dysmotility, polycystic kidney and scoliosis in medaka (Oryzias latipes). 28823919 2017